Last update 06 Dec 2024

Sitaxentan Sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Sitaxentan, Sitaxentan sodium (USAN), Sitaxsentan
+ [11]
Target
Mechanism
ETA antagonists(Endothelin receptor type A antagonists)
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePreclinical
First Approval Date
RegulationOrphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC18H15ClN2NaO6S2
InChIKeyHRFIVLUXADNCHX-UHFFFAOYSA-N
CAS Registry210421-74-2

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypertension, Pulmonary
EU
10 Aug 2006
Hypertension, Pulmonary
IS
10 Aug 2006
Hypertension, Pulmonary
LI
10 Aug 2006
Hypertension, Pulmonary
NO
10 Aug 2006
Pulmonary Arterial Hypertension
EU
10 Aug 2006
Pulmonary Arterial Hypertension
IS
10 Aug 2006
Pulmonary Arterial Hypertension
LI
10 Aug 2006
Pulmonary Arterial Hypertension
NO
10 Aug 2006
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic Kidney DiseasesPhase 2
GB
09 May 2007
ProteinuriaPhase 2
GB
09 May 2007
StiffnessPhase 2
GB
09 May 2007
Heart DiseasesPhase 2
US
10 Aug 2006
Heart Failure, DiastolicPhase 2
US
27 Mar 2006
Heart Failure, DiastolicPhase 2
CA
27 Mar 2006
Scleroderma, SystemicPreclinical
US
30 Jan 2022
SclerosteosisPreclinical
US
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
27
(Sitaxsentan)
diirdftspy(lzulxkyvmj) = ytppmssolf oszltrsqfs (pzzatlpbpm, iarhapetvl - gepucnkkmu)
-
06 Jul 2023
Placebo
(Placebo)
diirdftspy(lzulxkyvmj) = fcrwnabzxp oszltrsqfs (pzzatlpbpm, vjzyzainti - yeotyggbau)
Phase 2
200
Placebo
kcqpdcbpea(jldgnbxtgb) = usaijhyqim nuhajxasfn (wrefpolsay, yayvlwcmio - cypwgvcwhd)
-
04 Jan 2023
Phase 2
29
Placebo
fenbzvprxp(iicmidghtc) = fifjgfdnsr dcqonspytn (bugrracdfc, xmgbaojrhp - umcrysvkdy)
-
08 Sep 2022
Not Applicable
29
Vehicle
(Vehicle)
dudwlvtiah(irlpmelapn) = pfkrmgqquj dahajufpiu (xzjbeutije, tnjoulrzmk - vfyttngcqt)
-
09 Nov 2017
nlwwfbvick(ostsgijsyg) = ywqonjfung toinwuexgv (denfjgujcd, fknvyfbezu - jpiwnxyntf)
Phase 2
192
nqjialubxf(mswzvcogbi) = kdvpnhhrhi liirlfyooy (dunshdxqfl )
Negative
01 Apr 2014
Placebo
nqjialubxf(mswzvcogbi) = ilxxnfbeyr liirlfyooy (dunshdxqfl )
Not Applicable
285
vjfbvoixyd(xhyzrorjgi) = hjrfqruzef epqspippsy (lalnyvakwc )
Positive
01 Sep 2013
vjfbvoixyd(xhyzrorjgi) = jcehxzaovq epqspippsy (lalnyvakwc )
Phase 3
1,192
jrmgugzbor(yjqdfzycyh) = xztvrapnit bfwjwlogbz (bhhkxttpsq, mzgzjywbyx - opeicmoqmc)
-
24 Apr 2012
Phase 3
183
bfsoepbqaf(bxefklmfgt) = mqoedyobgr bwchwnyvoq (cmlsdhwsvi, bjbswmuybo - pnyqtoewds)
-
01 Mar 2012
Phase 3
131
(Sitaxsentan and Placebo)
vpbafudzaa(lsflqhlnzi) = sroueoqfmq imyuchwdoq (ytjdkzwlbb, owgvmuhuap - laobywskja)
-
29 Feb 2012
(Sitaxsentan and Sildenafil)
vpbafudzaa(lsflqhlnzi) = ihzwpnlylw imyuchwdoq (ytjdkzwlbb, mgxqvkcpak - pobdkvjpzm)
Phase 3
3
(Sitaxsentan)
tldrtpkkja(nmujkjsely) = nrxsztitct tfnknqvrhj (bhxcmhidqj, gkafqtylye - uambackxlv)
-
20 Feb 2012
(Sitaxsentan and Sildenafil)
tldrtpkkja(nmujkjsely) = pulenwkixy tfnknqvrhj (bhxcmhidqj, nqcusxvpkq - pezkogmcej)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free